Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014–2015

References

• Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose Deaths-United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64:1378–1382.
   PubMed Web of Science ®Google Scholar
• Center for Behavioral Health Statistics and Quality. Results from the 2015 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2016.
   Google Scholar
• McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635–2645.
   PubMed Web of Science ®Google Scholar
• Clark HW, Power AK, Le Fauve CE, Lopez EI. Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders. J Subst Abuse Treat.2008;34:3–13.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services and Office of the Surgeon General. Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. Washington, DC: U.S. Department of Health & Human Services; 2016.
   Google Scholar
• Institute of Medicine. Improving the Quality of Health Care for Mental and Substance-Use Conditions. Washington, DC: National Academies Press; 2006.
   Google Scholar
• Harris AH, Bowe T, Finney JW, Humphreys K. HEDIS initiation and engagement quality measures of substance use disorder care: impact of setting and health care specialty. Popul Health Manag. 2009;12:191–196.
   PubMed Web of Science ®Google Scholar
• National Committee for Quality Assurance. HEDIS® & performance measurement. http://www.ncqa.org/hedis-quality-measurement. Published 2018. Accessed June 25, 2018.
   Google Scholar
• Garnick DW, Horgan CM, Acevedo A, McCorry F, Weisner C. Performance measures for substance use disorders-what research is needed? Addict Sci Clin Pract. 2012;7:18.
   PubMedGoogle Scholar
• Selby JV, Schmittdiel JA, Lee J, et al. Meaningful variation in performance: what does variation in quality tell us about improving quality? Med Care. 2010;48:133–139.
   PubMed Web of Science ®Google Scholar
• Yarborough BJH, Chi FW, Green CA, et al. Patient and system characteristics associated with performance on the HEDIS measures of Alcohol and Other Drug Treatment Initiation and Engagement. J Addict Med. 2018;12(4):278–286.
   PubMed Web of Science ®Google Scholar
• Choi S, Adams SM, Morse SA, MacMaster S. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders. Subst. Use Misuse. 2015;50:653–663.
   PubMed Web of Science ®Google Scholar
• Greenfield SF, Brooks AJ, Gordon SM, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86:1–21.
   PubMed Web of Science ®Google Scholar
• McKellar JD, Harris AH, Moos RH. Predictors of outcome for patients with substance-use disorders five years after treatment dropout. J Stud Alcohol. 2006;67:685–693.
   PubMed Web of Science ®Google Scholar
• Mertens J, Weisner C. Predictors of alcohol and drug treatment seeking, initiation, and retention in an HMO. Research Society on Alcoholism 24th Annual Scientific Meeting. Montreal, Canada 2001.
   Google Scholar
• Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001;286:1715–1723.
   PubMed Web of Science ®Google Scholar
• Wells K, Klap R, Koike A, Sherbourne C. Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care. Am J Psychiatry. 2001;158:2027–2032.
   PubMed Web of Science ®Google Scholar
• Zemore SE, Murphy RD, Mulia N, et al. A moderating role for gender in racial/ethnic disparities in alcohol services utilization: Results from the 2000 to 2010 national alcohol surveys. Alcohol Clin Exp Res. 2014;38:2286–2296.
   PubMed Web of Science ®Google Scholar
• Mertens J, Weisner C. People who seek, start, and remain in treatment in an HMO: Who are they? FrontLines. 2003;6.
   Google Scholar
• Mulia N, Schmidt LA, Ye Y, Greenfield TK. Preventing disparities in alcohol screening and brief intervention: the need to move beyond primary care. Alcohol Clin Exp Res. 2011;35:1557–1560.
   PubMed Web of Science ®Google Scholar
• Mulia N, Tam TW, Schmidt LA. Disparities in the use and quality of alcohol treatment services and some proposed solutions to narrow the gap. PS. 2014;65:626–633.
   Google Scholar
• Mertens J, Weisner C, Sterling S. Disparities across treatment settings for the medically indigent: implications for substance abuse screening and interventions. FrontLines 2001;6:8.
   Google Scholar
• U.S. Congress. Patient Protection and Affordable Care Act, 42 U.S.C. § 18001. Public Law 111–148. Washington, DC: U.S. Government Printing Office; https://www.gpo.gov/fdsys/pkg/PLAW-111publ148/html/PLAW-111publ148.htm. Published 2010. Accessed March 7, 2018.
   Google Scholar
• Andersen R, Newman JF. Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc. 1973;51:95–124.
   PubMed Web of Science ®Google Scholar
• Satre DD, DeLorenze GN, Quesenberry CP, Tsai A, Weisner C. Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIV. PS. 2013;64:745–753.
   Google Scholar
• National Committee for Quality AssuranceSummary table of measures, product lines and changes. Hedis 2015 2015;2:8. (http://www.ncqa.org/Portals/0/HEDISQM/Hedis2015/List_of_HEDIS_2015_Measures.pdf. Published Accessed July 26, 2018.
   Google Scholar
• Agency for Healthcare Research and QualityEngagement of alcohol and other drug (AOD) treatment: percentage of members who initiated treatment and who had two or more additional services with a diagnosis of AOD within 30 days of the initiation visit. National Quality Measures Clearinghouse 2018. https://www.qualitymeasures.ahrq.gov/summaries/summary/49778. Published October 2015. Accessed June 21.
   Google Scholar
• Health Care Systems Research Network. Who we are. http://www.hcsrn.org/en/ Published 2015. Accessed July 10, 2018.
   Google Scholar
• National Committee for Quality Assurance. HEDIS 2015 QRS Technical Update. Washington (DC): National Committee for Quality Assurance (NCQA); http://www.ncqa.org/Portals/0/HEDISQM/Hedis2015/HEDIS%20QRS%202015%20Technical%20Update_Final.pdf. Published October 1 2014. Accessed July 26, 2018.
   Google Scholar
• HCUP CCS. Healthcare Cost and Utilization Project (HCUP). Rockville,MD: Agency for Healthcare Research and Quality; https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp#examples. Published 2017. Accessed July 17, 2018.
   Google Scholar
• Stein MD. Medical consequences of substance abuse. Psychiatr Clin North Am. 1999;22:351–370.
   PubMed Web of Science ®Google Scholar
• Sikkink J, Fleming MF. Adverse health effects and medical complications of alcohol, nicotine, and drug abuse. In: Fleming MF and Barry KL eds. Addictive Disorders: A Practical Guide to Treatment. St. Louis: Mosby-Year Book Primary Care Series; 1992:145–168.
   Google Scholar
• National Institute on Alcohol Abuse and Alcoholism. Seventh Special Report to the U.S. Congress on Alcohol and Health. Rockville, MD: U.S. Dept. of Health and Human Services Public Health Service; DHHS Publication No. ADM 90-1656. https://babel.hathitrust.org/cgi/pt?id=pur1.32754062634468;view=1up;seq=3. Published 1990. Accessed January 12, 2018.
   Google Scholar
• Moos RH, Brennan PL, Mertens JR. Diagnostic subgroups and predictors of one-year re-admission among late-middle-aged and older substance abuse patients. J Stud Alcohol. 1994;55:173–183.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Nelson CB, McGonagle KA, et al. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996;66:17–31.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Charlson RE, Peterson JC, et al. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61:1234–1240.
   PubMed Web of Science ®Google Scholar
• Garnick DW, Lee MT, Chalk M, et al. Establishing the feasibility of performance measures for alcohol and other drugs. J Subst Abuse Treat. 2002;23:375–385.
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services. Subtitle B—Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008. H. R. 1424—117; https://www.cms.gov/Regulations-and-Guidance/Health-Insurance-Reform/HealthInsReformforConsume/downloads/MHPAEA.pdf. Published 2008. Accessed June 25, 2018.
   Google Scholar
• Meaningful use. HealthIT.gov. Washington, DC: Office of the National Coordinator for Health Information Technology; http://www.healthit.gov/policy-researchers-implementers/meaningful-use. Published 2013. Accessed July 10, 2018.
   Google Scholar